On Friday, Werewolf Therapeutics Inc (NASDAQ: HOWL) opened lower -6.43% from the last session, before settling in for the closing price of $1.4. Price fluctuations for HOWL have ranged from $0.60 to $2.75 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -20.76%. Company’s average yearly earnings per share was noted 5.83% at the time writing. With a float of $31.82 million, this company’s outstanding shares have now reached $45.34 million.
The extent of productivity of a business whose workforce counts for 46 workers is very important to gauge.
Werewolf Therapeutics Inc (HOWL) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Werewolf Therapeutics Inc is 30.42%, while institutional ownership is 34.10%. The most recent insider transaction that took place on Oct 30 ’25, was worth 6,987. Before that another transaction happened on Oct 30 ’25, when Company’s Shareholder proposed sale 8,679 for $1.56, making the entire transaction worth $13,539.
Werewolf Therapeutics Inc (HOWL) Latest Financial update
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.38 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.39) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.41 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 5.83% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -3.27% during the next five years compared to -20.76% drop over the previous five years of trading.
Werewolf Therapeutics Inc (NASDAQ: HOWL) Trading Performance Indicators
Check out the current performance indicators for Werewolf Therapeutics Inc (HOWL). In the past quarter, the stock posted a quick ratio of 5.30.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.64, a number that is poised to hit -0.38 in the next quarter and is forecasted to reach -1.35 in one year’s time.
Technical Analysis of Werewolf Therapeutics Inc (HOWL)
The latest stats from [Werewolf Therapeutics Inc, HOWL] show that its last 5-days average volume of 0.94 million was superior to 0.49 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 18.90%.
During the past 100 days, Werewolf Therapeutics Inc’s (HOWL) raw stochastic average was set at 21.61%, which indicates a significant decrease from 30.67% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1503 in the past 14 days, which was higher than the 0.1231 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.6167, while its 200-day Moving Average is $1.2796. Now, the first resistance to watch is $1.4665. This is followed by the second major resistance level at $1.6229. The third major resistance level sits at $1.8162. If the price goes on to break the first support level at $1.1168, it is likely to go to the next support level at $0.9235. The third support level lies at $0.7671 if the price breaches the second support level.
Werewolf Therapeutics Inc (NASDAQ: HOWL) Key Stats
There are currently 45,729K shares outstanding in the company with a market cap of 59.90 million. Presently, the company’s annual sales total 1,890 K according to its annual income of -70,520 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -17,980 K.
